Drug Type TCR therapy |
Synonyms |
Mechanism CMV protein inhibitors(CMV Protein inhibitors), EBV Protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization BriSTAR Immunotech LimitedStartup |
Active Organization BriSTAR Immunotech LimitedStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infectious Diseases | Preclinical | CN | BriSTAR Immunotech LimitedStartup | 28 Jun 2023 |